SCIENTIFIC publications

/cun/en/investigacion/publicaciones-cientificas/areaMain/02
  • Subcutaneous Delivery of Daratumumab in Relapsed or Refractory Multiple Myeloma

    Usmani SZ (1), Nahi H (2), Mateos MV (3), van de Donk NWCJ (4), Chari A (5), Kaufman JL (6), Moreau P (7), Oriol A (8), Plesner T (9), Benboubker L (10), Hellemans P (11), Masterson T (12), Clemens PL (13), Luo M (12), Liu K (14), San Miguel J (15)

    (1) Levine Cancer Institute/Atrium Health, United States
    (2) Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Sweden.
    (3) Department of Hematology, University Hospital of Salamanca7IBSAL, Spain.
    (4) Hematology, VU University Medical Center, Netherlands.
    (5) Mount Sinai Hospital, United States.
    (6) Hematology and Medical Oncology, Emory University Winship Cancer Institute, United States.
    (7) Department of Hematology, Centre Hospitalier Universitaire de Nantes, France.
    (8) Clinical Hematology, ICO - Hosp Germans Trias i Pujol, Spain.
    (9) Hematology, Vejle Hospital, Denmark.
    (10) Hematology & cell therapy, CHRU TOURS, France.
    (11) Janssen Research & Development, LLC, Belgium.
    (12) Janssen Research & Development, LLC, United States.
    (13) Janssen R&D, United States.
    (14) Biostatistics, Johnson & Johnson PRD, LLC, United States.
    (15) Clinica Universidad de Navarra, Universidad de Navarra, Spain.

    Blood 03 JULY 2019

  • Screening in Lung Cancer: The Latest Evidence

    Seijo LM (1), Trujillo JC (2), Zulueta JJ (3).

    (1) Clínica Universidad de Navarra, Madrid, España; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III, España.
    (2) Hospital de la Santa Creu i Sant Pau, Barcelona, España; Coordinador Área de Oncología Torácica, SEPAR, España.
    (3) Clínica Universidad de Navarra, Pamplona, España.

    Archivos de Bronconeumología 13 JUNE 2019

  • Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers

    Carmona-Abellan M (1), Gabilondo I (2), Murueta-Goyena A (3), Khurana V (4), Tijero B (5), Luquin MR (6), Acera M (1), Del Pino R (1), Gardeazabal J (7), Martínez-Valbuena I (6), Sanchez-Pernaute R (8), Gómez-Esteban JC (9)

    (1) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain.
    (2) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain; Ikerbasque: The Basque Foundation for Science, Bilbao, Spain.
    (3) Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain.
    (4) Ann Romney Center for Neurologic Disease, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
    (5) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain.
    (6) Department of Neurology, Clínica Universitaria de Navarra, Universidad de Navarra, Pamplona, Spain.
    (7) Dermatology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain.
    (8) Andalusian Initiative for Advanced Therapies, Junta de Andalusia, Seville, Spain.
    (9) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain

    Parkinsonism Related Disorders 05 JUNE 2019

  • Spanish consensus document on bariatric endoscopy

    Espinet Coll E (1), López-Nava Breviere G (2), Nebreda Durán J (3), Marra-López Valenciano C (4), Turró Arau R (5), Esteban López-Jamar JM (6), Muñoz-Navas M (7).

    (1) Aparato Digestivo, Gastrodex. Hospital Universitario Quiron Dexeus, España.
    (2) Hospital Universitario Madrid San Chinarro.
    (3) Clínica Diagonal, España.
    (4) Complejo Hospitalario de Navarra., España.
    (5) Hospital Quirón Teknon.
    (6) Hospital Clínico San Carlos.
    (7) Aparato Digestivo, Clínica Universidad de Navarra.

    Revista Española de Enfermedades Digestivas 18 JANUARY 2019

  • Surface scanning for 3D dose calculation in intraoperative electron radiation therapy

    García-Vázquez V (1), Sesé-Lucio B (2), Calvo FA (2,3,4,5), Vaquero JJ (2,6), Desco M (2,6,7,8), Pascau J (2,6,7).

    (1) Hospital General Universitario Gregorio Marañón, Unidad de Medicina y Cirugía Experimental (Instituto de Investigación Sanitaria Gregorio Marañón), Madrid, Spain.
    (2) Hospital General Universitario Gregorio Marañón, Unidad de Medicina y Cirugía Experimental (Instituto de Investigación Sanitaria Gregorio Marañón), Madrid, Spain.
    (3) Departamento de Oncología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
    (4) Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
    (5) Clínica Universidad de Navarra, Madrid, Spain.
    (6) Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, Madrid, Spain.
    (7) Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
    (8) Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

    Radiation Oncology 07 DECEMBER 2018

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra